| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/26/2004 | CN1150943C Immobilized activity stabilized LHRH-antagonist complexes, method for prodn. thereof |
| 05/26/2004 | CN1150895C Dry Powder for inhalation |
| 05/25/2004 | USRE38522 Demineralized lyophilized allograft bone powder in a n,o-carboxymethylchitosan water carrier solution |
| 05/25/2004 | US6740794 Skewing percentage of females to males in shrimp or prawn |
| 05/25/2004 | US6740760 Such as 1-((s)-3-mercapto-2-methyl-propionyl)-(r)-pyrrol-idine-2-carboxylic acid for treating diseases associated with amyloidosis (alzheimer's disease, diabetes, and familial amyloid polyneuropathy) |
| 05/25/2004 | US6740751 Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells |
| 05/25/2004 | US6740750 Ribozyme sequences related to hiv resistance |
| 05/25/2004 | US6740739 Substitutional variants of APO-2 ligand |
| 05/25/2004 | US6740738 Antibodies binding to polypeptides encoded by the genes |
| 05/25/2004 | US6740736 Purification of fibrinogen from milk by use of cation exchange chromatography |
| 05/25/2004 | US6740735 Hypertriglyceridemia |
| 05/25/2004 | US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury. |
| 05/25/2004 | US6740678 Screening; administering angiogenesis inhibitor |
| 05/25/2004 | US6740647 Amidines and hydroxyamidine derivatives |
| 05/25/2004 | US6740639 L-tyrosyl-d-alanyl-glycyl-n-methylphenylalanyl-glycyl -isopropylamide and cyclodextrin derivatives; analgesic, antiinflammatory, nonaddictive properties |
| 05/25/2004 | US6740638 Amino acid sequence has 87-99 peptide residues |
| 05/25/2004 | US6740636 Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection |
| 05/25/2004 | US6740635 Aids therapy, respiratory syncytial virus |
| 05/25/2004 | US6740634 Biologically active peptide (an lh-rh derivative), hydroxynaphthoic acid (3-hydroxy-2-naphthoic acid) and a biodegradable polymer (lactic acid-glycolic acid copolymer); prostatic cancer or hypertrophy, endometriosis, hysteromyoma |
| 05/25/2004 | US6740523 Administering 14-3-3 sigma protein for suppressing growth of tumor cells |
| 05/25/2004 | US6740522 Rank (receptor activator of neurotrophic factor-kappa b) ligand (rankl) polypeptides; immunoregulatory activity |
| 05/25/2004 | US6740512 Eukaryotic neutral sphingomyelinase (nsmase); used in drugs and in diagnosis |
| 05/25/2004 | US6740334 Bone resorption suppressing agent |
| 05/25/2004 | US6740321 Administering to treat hypothyroidism or hyperthyroidism |
| 05/25/2004 | US6740320 Recombinant P53 adenovirus methods and compositions |
| 05/25/2004 | CA2185457C Use of nitric oxide-releasing polymers to treat restenosis and related disorders |
| 05/21/2004 | WO2004042402A2 Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) |
| 05/21/2004 | WO2004042394A2 Method for providing natural therapeutic agents with high therapeutic index |
| 05/21/2004 | WO2004042361A2 Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 05/21/2004 | WO2004042077A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b) |
| 05/21/2004 | WO2004042076A2 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4a (pde4a) |
| 05/21/2004 | WO2004042075A2 Inactivated ga1 - nac - transferases, methods for inhibitors of such transferases and their use |
| 05/21/2004 | WO2004042068A2 Injectable and bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation |
| 05/21/2004 | WO2004042064A2 Disorders of lipid metabolism |
| 05/21/2004 | WO2004042063A1 Pharmaceutical composition for preparing a medicine for treating and/or preventing a pathology related to an obsessive behaviour or obesity |
| 05/21/2004 | WO2004042056A1 Physiologically active polypeptide and its antibody and use thereof |
| 05/21/2004 | WO2004042049A1 Method of degrading hardly degradable protein |
| 05/21/2004 | WO2004042027A2 Allele-specific rna interference |
| 05/21/2004 | WO2004042025A2 Cell-specific adenovirus vector comprising ebv-specific promoter |
| 05/21/2004 | WO2004042024A2 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF HIF-1 ALPHA |
| 05/21/2004 | WO2004042014A2 Mono- and diacylglycerol acyltransferases and methods of use thereof |
| 05/21/2004 | WO2004042011A2 Promotion of peroxisomal catalase function in cells |
| 05/21/2004 | WO2004041859A2 Peptide fragments of the harp factor inhibiting angiogenesis |
| 05/21/2004 | WO2004041857A2 Mutant of clostridium difficile toxin b and methods of use |
| 05/21/2004 | WO2004041855A1 Peptides for preventing, diagnosing and treating animal and/or human leptospirosis |
| 05/21/2004 | WO2004041850A1 Novel fprl1 ligands and use thereof |
| 05/21/2004 | WO2004041846A2 INDUCIBLE LIGAND FOR α1β1 INTEGRIN AND USES |
| 05/21/2004 | WO2004041845A2 Templated native silk smectic gels |
| 05/21/2004 | WO2004041843A2 Hop - a novel cardiac-restricted transcriptional factor potentially useful for cardiac regeneration and specification |
| 05/21/2004 | WO2004041838A1 Regulation of transcription elongation factors |
| 05/21/2004 | WO2004041778A2 A method for increasing synaptic growth or plasticity |
| 05/21/2004 | WO2004041719A1 Carbon nanotube construct and process for producing the same |
| 05/21/2004 | WO2004041309A1 Drugs comprising combination of elastase inhibitor with blood coagulation system and/or fibrinolysis system enzyme inhibitor |
| 05/21/2004 | WO2004041304A2 Pain relief agents |
| 05/21/2004 | WO2004041303A1 Oral formulation or botulinum toxin and use thereof for treating peptic ulcers and gastroesophageal reflux disease |
| 05/21/2004 | WO2004041302A1 Pharmaceutical composition comprising a tissue factor antagonist and a blood glucose regulator |
| 05/21/2004 | WO2004041301A1 Antidiuretics |
| 05/21/2004 | WO2004041300A1 Chaperonin 10 immunosuppression |
| 05/21/2004 | WO2004041299A1 Dc-sign blockers and their use for preventing or treating viral infections. |
| 05/21/2004 | WO2004041298A1 Liposomal composition comprising haptotactic peptides |
| 05/21/2004 | WO2004041297A2 Modified cytokines for use in cancer therapy |
| 05/21/2004 | WO2004041296A2 Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides |
| 05/21/2004 | WO2004041221A1 Use of 3-position cyclosporin derivatives for hair growth |
| 05/21/2004 | WO2004041212A2 Apkc isoforms in nervous system disorders and cancer |
| 05/21/2004 | WO2004041205A2 Ha4, a new osteoblast- and chondrocyte-specific small secreted peptide, compositions and methods of use |
| 05/21/2004 | WO2004041203A2 Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
| 05/21/2004 | WO2004041194A2 Inhibition of hiv-1 replication |
| 05/21/2004 | WO2004041193A2 HUMAN TYPE II DIABETES GENE-Kv CHANNEL-INTERACTING PROTEIN (KChIP1) LOCATED ON CHROMOSOME 5 |
| 05/21/2004 | WO2004041190A2 Composition for the treatment of macular degenration |
| 05/21/2004 | WO2004041182A2 M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever |
| 05/21/2004 | WO2004041181A2 Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment and management of macular degeneration |
| 05/21/2004 | WO2004041179A2 Scavenger receptor b1 (cla-1) targeting for the treatment of infection, sepsis and inflammation |
| 05/21/2004 | WO2004041176A2 The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus |
| 05/21/2004 | WO2004041172A2 Interferon antagonists useful for the treatment of interferon related diseases |
| 05/21/2004 | WO2004041170A2 Compositions and methods for the treatment of immune related diseases |
| 05/21/2004 | WO2004041159A2 Composition and method for enhancing immune response of swine |
| 05/21/2004 | WO2004041155A2 Treatment and prevention of abnormal scar formation in keloids and other cutaneous or internal wounds or lesions |
| 05/21/2004 | WO2004041153A2 Pharmaceutical composition including low dosages of desmopressin |
| 05/21/2004 | WO2004041152A2 Antigenic targets of autoimmune sensorineural hearing loss (aisnhl) and development of tests fro diagnosis and management of aisnhl |
| 05/21/2004 | WO2004041118A2 Therapeutic compositions for drug delivery to and through covering epithelia |
| 05/21/2004 | WO2004041115A2 Novel human elastases and stress urinary incontinence |
| 05/21/2004 | WO2004041106A1 Methods and systems for enabling and stabilizing tooth movement |
| 05/21/2004 | WO2004041071A2 Compositions, systems, and methods for focusing a cell-mediated immune response |
| 05/21/2004 | WO2004041067A2 Prevention and treatment of synucleinopathic disease |
| 05/21/2004 | WO2004041065A2 METHODS FOR PROPHYLAXIS AND TREATMENT OF HER-2/neu TUMORS |
| 05/21/2004 | WO2004034061A3 Method for determining the susceptibility of a subject to infection |
| 05/21/2004 | WO2004029091A3 FVII OR FVIIa VARIANTS HAVING INCREASED CLOTTING ACTIVITY |
| 05/21/2004 | WO2004027020A9 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 05/21/2004 | WO2004026330B1 Methods and preparations for curing critically ill patients |
| 05/21/2004 | WO2004026326A3 Antigen uptake receptor for candida albicans on dendritic cells |
| 05/21/2004 | WO2004024925A8 Collectin-complement activating protein chimeras |
| 05/21/2004 | WO2004022709A3 Epitope sequences |
| 05/21/2004 | WO2004018629A8 Stars-a muscle-specification-binding protein |
| 05/21/2004 | WO2004016244A3 Pharmaceutical compositions for buccal delivery of pain relief medications |
| 05/21/2004 | WO2004016243A3 Methods of administering and enhancing absorption of pharmaceutical agents |
| 05/21/2004 | WO2004014413A8 Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto |
| 05/21/2004 | WO2004011029A3 Pharmaceutical compositions for penis enlargement |
| 05/21/2004 | WO2004009759A8 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 05/21/2004 | WO2004005476A3 Nucleic acid compositions for stimulating immune responses |
| 05/21/2004 | WO2004000817A3 Benzimidazole compounds and their use as estrogen agonists/antagonists |